Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 28, 2017; 23(8): 1458-1468
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1458
Published online Feb 28, 2017. doi: 10.3748/wjg.v23.i8.1458
Figure 1 Selection and enrollment of cirrhotic patients to the study.
HCV: Hepatitis C virus; NAFLD: Nonalcoholic fatty liver disease.
Figure 2 Prevalence of metabolic factors and of cardiovascular complications in cryptogenic cirrhosis and hepatitis C virus-related cirrhosis.
All factors are significantly higher in cryptogenic cirrhosis (P < 0.01 vs HCV-related cirrhosis). HCV: Hepatitis C virus; IFG: Impaired fasting glucose.
Figure 3 Occurrence of hepatocellular carcinoma among 102 patients with cryptogenic cirrhosis and 110 patients with hepatitis C virus-related cirrhosis and its distribution among Child-Pugh class.
HCV: Hepatitis C virus; HCC: Hepatocellular carcinoma.
Figure 4 Cumulative probability of overall survival after cirrhosis detection according to different significant predictors of mortality.
A: Cumulative probability of overall survival according to age at diagnosis; P = 0.002 by log-rank test; B: Cumulative probability of overall survival according to Child Class at diagnosis; P < 0.001 by log-rank test; C: Cumulative probability of overall survival according to baseline sodium levels; P = 0.020 by log-rank test; D: Cumulative probability of overall survival according to baseline creatinine levels; P = 0.017 by log-rank test.
- Citation: Rinaldi L, Nascimbeni F, Giordano M, Masetti C, Guerrera B, Amelia A, Fascione MC, Ballestri S, Romagnoli D, Zampino R, Nevola R, Baldelli E, Iuliano N, Rosato V, Lonardo A, Adinolfi LE. Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis. World J Gastroenterol 2017; 23(8): 1458-1468
- URL: https://www.wjgnet.com/1007-9327/full/v23/i8/1458.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i8.1458